BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Diagnosis
409 results:

  • 1. Diagnostic accuracy of clinical visual assessment using endoscopic images for nasal cavity mass lesions.
    Kwon KW; Yu MS
    Sci Prog; 2024; 107(2):368504241248004. PubMed ID: 38683182
    [No Abstract]    [Full Text] [Related]  

  • 2. A statistical symptomatic evaluation on SAPHO syndrome from 56 cases of confirmed diagnosis and 352 cases of non-SAPHO involvement.
    Qiu C; Li M; Wu Q; Zhou J; Liu T; Li J; Liu J; Cheng L; Hong Y; Luo D; Yan J; Pan W; Wang Z; Wang Q; Liu X; Wang L
    Clin Rheumatol; 2024 May; 43(5):1763-1775. PubMed ID: 38446355
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Exploring risk factors and molecular targets in leukemia patients with COVID-19: a bioinformatics analysis of differential gene expression.
    Ullah MA; Moin AT; Nipa JF; Islam NN; Johora FT; Chowdhury RH; Islam S
    J Leukoc Biol; 2024 Mar; 115(4):723-737. PubMed ID: 38323674
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma.
    Kim S; Chung H; Kwak JE; Kim YR; Park CH; Kim Y; Cheong JW; Wu J; Shin EC; Cho H; Kim JS
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38191242
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Role of Apparent Diffusion Coefficient Map-Based First- and High-Order Radiomic Features for the Discrimination of Sacral Chordomas and Chondrosarcomas With Overlapping Conventional Imaging Features.
    Amini B; Chenglei L; Duran-Sierra E; Wang WL; Canjirathinkal MA; Moradi H; Green WN; Madewell JE; Costelloe CM; Murphy WA; Valenzuela RF
    JCO Precis Oncol; 2023 Sep; 7():e2300243. PubMed ID: 38127828
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: Myosin light chain kinase and caldesmon.
    Li H; Lin G; Cui M; Wang L; Ding D; Li X; Fan X; Yang Q; Wang Y; Kang C; Zhang L; Liu B; Su J
    Medicine (Baltimore); 2023 Dec; 102(48):e36414. PubMed ID: 38050320
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. HLA-B27 did not protect against COVID-19 in patients with axial spondyloarthritis - data from the ReumaCov-Brasil Registry.
    Mota GD; Marques CL; Ribeiro SL; Albuquerque C; Castro G; Fernandino D; Omura F; Ranzolin A; Resende G; Silva N; Souza M; Studart S; Xavier R; Yazbek M; Pinheiro MM
    Adv Rheumatol; 2023 Nov; 63(1):56. PubMed ID: 38031143
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The mitochondrial energy metabolism pathway-related signature predicts prognosis and indicates immune microenvironment infiltration in osteosarcoma.
    Yang S; Liu L; Liu X; Li X; Zheng Y; Ren Z; Wang R; Wang Y; Li Q
    Medicine (Baltimore); 2023 Nov; 102(46):e36046. PubMed ID: 37986397
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Machine learning based on SPECT/CT to differentiate bone metastasis and benign bone lesions in lung malignancy patients.
    Wang H; Chen Y; Qiu J; Xie J; Lu W; Ma J; Jia M
    Med Phys; 2024 Apr; 51(4):2578-2588. PubMed ID: 37966123
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Risk factors for distant metastasis of Chondrosarcoma in the middle-aged and elderly people.
    Deng GH
    Medicine (Baltimore); 2023 Nov; 102(44):e35562. PubMed ID: 37932996
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Detection of early prognostic biomarkers for metastasis of Ewing's sarcoma in pediatric patients.
    Ezzeldin S; Osama A; Anwar AM; Mahgoub S; Ahmed EA; Farid N; Zamzam M; El Ghoneimy A; Magdeldin S
    Life Sci; 2023 Dec; 334():122237. PubMed ID: 37926299
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis.
    Arthur A; Orton MR; Emsley R; Vit S; Kelly-Morland C; Strauss D; Lunn J; Doran S; Lmalem H; Nzokirantevye A; Litiere S; Bonvalot S; Haas R; Gronchi A; Van Gestel D; Ducassou A; Raut CP; Meeus P; Spalek M; Hatton M; Le Pechoux C; Thway K; Fisher C; Jones R; Huang PH; Messiou C
    Lancet Oncol; 2023 Nov; 24(11):1277-1286. PubMed ID: 37922931
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Impact of Consolidative Radiation on Overall and Progression-Free Survival in Pediatric, Adolescent, and Young Adult Metastatic bone and Soft Tissue Sarcoma.
    Chang L; D'Amiano A; Bhatia R; Yenokyan G; Llosa NJ; Ladle BH; Meyer CF; Levin AS; Pratilas CA; Ladra M; Acharya S
    Int J Radiat Oncol Biol Phys; 2024 Feb; 118(2):474-484. PubMed ID: 37797747
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. An eXplainable Artificial Intelligence analysis of Raman spectra for thyroid cancer diagnosis.
    Bellantuono L; Tommasi R; Pantaleo E; Verri M; Amoroso N; Crucitti P; Di Gioacchino M; Longo F; Monaco A; Naciu AM; Palermo A; Taffon C; Tangaro S; Crescenzi A; Sodo A; Bellotti R
    Sci Rep; 2023 Oct; 13(1):16590. PubMed ID: 37789191
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comprehensive bioinformatics analysis reveals the oncogenic role of FoxM1 and its impact on prognosis, immune microenvironment, and drug sensitivity in osteosarcoma.
    Shi S; Wang Q; Du X
    J Appl Genet; 2023 Dec; 64(4):779-796. PubMed ID: 37782449
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report.
    Kowarsch F; Maurer-Granofszky M; Weijler L; Wödlinger M; Reiter M; Schumich A; Feuerstein T; Sala S; Nováková M; Faggin G; Gaipa G; Hrusak O; Buldini B; Dworzak MN
    Cytometry A; 2024 Jan; 105(1):24-35. PubMed ID: 37776305
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung cancer Patients.
    Leest PV; Janning M; Rifaela N; Azpurua MLA; Kropidlowski J; Loges S; Lozano N; Sartori A; Irwin D; Lamy PJ; Hiltermann TJN; Groen HJM; Pantel K; Kempen LCV; Wikman H; Schuuring E
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686200
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Impact of Prior cancer on the Prognosis of Patients with Chondrosarcoma: A Population-Based Study of the SEER Database.
    Qian J; Dai S; Wang H
    Altern Ther Health Med; 2023 Nov; 29(8):674-679. PubMed ID: 37678875
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. C-C Motif Chemokine Ligand 5 (CCL5): A Potential Biomarker and Immunotherapy Target for Osteosarcoma.
    Zheng H; Wang Y; Li F
    Curr Cancer Drug Targets; 2024; 24(3):308-318. PubMed ID: 37581517
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Development and validation a model for predicting overall survival of bladder cancer with lung metastasis: a population-based study.
    Liu L; Sun FZ; Zhang PY; Xiao Y; Ni HX
    Eur J Med Res; 2023 Aug; 28(1):279. PubMed ID: 37559152
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 21.